PubRank

Vedat Schwenger

Author PubWeight™ 70.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011 6.35
2 Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Crit Care 2012 1.90
3 Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. Blood 2011 1.83
4 Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 2008 1.81
5 Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol 2013 1.78
6 Clinical value of automatic reporting of estimated glomerular filtration rate in geriatrics. Gerontology 2008 1.54
7 Malignancy in renal transplantation. J Am Soc Nephrol 2004 1.50
8 Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. Transpl Int 2012 1.47
9 C. elegans as model for the study of high glucose- mediated life span reduction. Diabetes 2009 1.45
10 Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients. J Hypertens 2008 1.42
11 The influence of haemodialysis on haemodynamic measurements using transpulmonary thermodilution in patients with septic shock: an observational study. Eur J Anaesthesiol 2013 1.40
12 Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement. J Rheumatol 2013 1.39
13 Acute phase reaction to gadolinium-DTPA in dialysis patients. Nephrol Dial Transplant 2008 1.39
14 Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial. Am J Kidney Dis 2011 1.27
15 Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 2002 1.24
16 Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood 2011 1.17
17 Sirolimus in renal transplantation. Nephrol Dial Transplant 2007 1.15
18 Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc Natl Acad Sci U S A 2012 1.11
19 Antifibrotic actions of mycophenolic acid. Clin Transplant 2006 1.08
20 Do AV fistulas contribute to cardiac mortality in hemodialysis patients? Semin Dial 2002 1.08
21 Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003 1.06
22 Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates. Perit Dial Int 2008 1.00
23 Pharmacokinetics of linezolid in septic patients with and without extended dialysis. Eur J Clin Pharmacol 2009 0.92
24 Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversible. Nephron 2002 0.90
25 Aquaporin-1 channel function is positively regulated by protein kinase C. J Biol Chem 2007 0.89
26 Glucose degradation products result in cardiovascular toxicity in a rat model of renal failure. Perit Dial Int 2010 0.89
27 ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption. Transplantation 2012 0.89
28 An integrative approach for the transplantation of high-risk sensitized patients. Transplantation 2010 0.88
29 Nanotube action between human mesothelial cells reveals novel aspects of inflammatory responses. PLoS One 2011 0.87
30 Salt--a potential 'uremic toxin'? Blood Purif 2006 0.86
31 Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus. Arthritis Rheumatol 2014 0.86
32 Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. J Am Soc Nephrol 2011 0.86
33 Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrol Dial Transplant 2007 0.86
34 Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients. Br J Clin Pharmacol 2010 0.86
35 Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure. J Am Soc Nephrol 2002 0.85
36 RAGE expression in the human peritoneal membrane. Nephrol Dial Transplant 2008 0.85
37 Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am J Ther 2013 0.85
38 Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil. Rheumatology (Oxford) 2010 0.84
39 Lifestyle modification and progressive renal failure. Nephrology (Carlton) 2005 0.84
40 How should we manage anaemia in patients with diabetes? Nephrol Dial Transplant 2002 0.84
41 Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading. Nephrol Dial Transplant 2007 0.83
42 Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T. Nephron Clin Pract 2007 0.82
43 Uremia aggravates left ventricular remodeling after myocardial infarction. Am J Nephrol 2010 0.82
44 Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption. Transplantation 2015 0.82
45 Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis. Atheroscler Suppl 2013 0.81
46 Human RAGE antibody protects against AGE-mediated podocyte dysfunction. Nephrol Dial Transplant 2012 0.81
47 Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats. J Mol Med (Berl) 2008 0.81
48 Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. Clin J Am Soc Nephrol 2010 0.81
49 Good MRI images: to Gad or not to Gad? Pediatr Nephrol 2007 0.81
50 Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus. Transplantation 2009 0.80
51 Dual regulation of renal Kir7.1 potassium channels by protein Kinase A and protein Kinase C. Biochem Biophys Res Commun 2008 0.80
52 Cellular effects of everolimus and sirolimus on podocytes. PLoS One 2013 0.80
53 Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography. Transplantation 2012 0.80
54 Immunoadsorption in nephrology and kidney transplantation. Nephrol Dial Transplant 2010 0.79
55 Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats. Basic Res Cardiol 2009 0.79
56 Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells. Pediatr Nephrol 2012 0.79
57 Prognostic value of standard parameters as predictors for long-term renal replacement therapy after liver transplantation. Nephron Clin Pract 2011 0.79
58 Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis. Am J Kidney Dis 2002 0.79
59 A nephrotic patient with tumour necrosis factor receptor-associated periodic syndrome, IgA nephropathy and CNS involvement. Nephrol Dial Transplant 2006 0.78
60 The patient with C-ANCA/PR3-ANCA-positive crescentic pauci-immune glomerulonephritis and recurrence of nephritic sediment. Nephrol Dial Transplant 2008 0.77
61 Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. Transplantation 2005 0.77
62 The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial. Trials 2014 0.77
63 daf-16/FOXO and glod-4/glyoxalase-1 are required for the life-prolonging effect of human insulin under high glucose conditions in Caenorhabditis elegans. Diabetologia 2014 0.77
64 The receptor for advanced glycation end-products (RAGE) plays a key role in the formation of nanotubes (NTs) between peritoneal mesothelial cells and in murine kidneys. Cell Tissue Res 2014 0.77
65 Psychosocial and physical outcome following kidney donation-a retrospective analysis. Transpl Int 2015 0.77
66 Potential role of nanotubes in context of clinical treatments? Commun Integr Biol 2013 0.76
67 Recompensation of heart and kidney function after treatment with peritoneal dialysis in a case of congestive heart failure. Case Rep Med 2011 0.75
68 Hepatic and renal failure after anterior myocardial infarction induced apical ventricular septal defect. Case Rep Med 2011 0.75
69 Lymphoid interstitial lung disease in a patient with acute tubulointerstitial nephritis and uveitis: a new facet of a rare syndrome? Am J Kidney Dis 2006 0.75
70 [Erythropoiesis stimulating agents]. Ther Umsch 2011 0.75
71 Is the sauna a common place for experiencing acute renal failure? Nephrol Dial Transplant 2005 0.75
72 Transmission of malignancy with solid organ transplants. Transplantation 2005 0.75
73 Hemodialysis--from early days to tomorrow. Contrib Nephrol 2005 0.75
74 Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension. Respiration 2017 0.75
75 [Dialysis in Germany: new medications and new technical possibilities. Interview by Sonja Böhm]. Dtsch Med Wochenschr 2005 0.75